Platinum-resistant ovarian cancer
Clinical trials for Platinum-resistant ovarian cancer explained in plain language.
Never miss a new study
Get alerted when new Platinum-resistant ovarian cancer trials appear
Sign up with your email to follow new studies for Platinum-resistant ovarian cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an amino acid boost the power of ovarian cancer treatment?
Disease control Not yet recruitingThis phase 1 trial is testing whether adding arginine, a common amino acid, to standard chemotherapy and immunotherapy can help people with platinum-resistant ovarian, fallopian tube, or peritoneal cancer. The study includes about 24 adults whose cancer has stopped responding to …
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase 1 • Sponsor: Rebecca Arend • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug aims to outsmart Chemotherapy-Resistant ovarian cancer
Disease control Not yet recruitingThis phase 3 trial tests an experimental drug called SYS6043 against standard chemotherapy in people with platinum-resistant ovarian, primary peritoneal, or fallopian tube cancer. Participants are randomly assigned to receive either SYS6043 or one of three standard chemotherapies…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase 3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat ovarian and endometrial cancers
Disease control Not yet recruitingThis early-phase trial tests a one-time treatment called OPB-201, where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells that carry a protein called PRAME. The study will enroll 30 adults with recurrent endometrial cancer or platinum-…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase 1 • Sponsor: Outpace Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common blood pressure pill boost chemo for tough ovarian cancer?
Disease control Not yet recruitingThis study tests whether adding losartan, a blood pressure medication, to weekly paclitaxel chemotherapy can shrink tumors in people with ovarian cancer that no longer responds to platinum-based drugs. About 27 adults with advanced ovarian, fallopian tube, or primary peritoneal c…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC